Edition:
United States

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

4.37USD
21 Sep 2018
Change (% chg)

$-0.22 (-4.79%)
Prev Close
$4.59
Open
$4.53
Day's High
$4.53
Day's Low
$4.32
Volume
65,157
Avg. Vol
71,828
52-wk High
$5.82
52-wk Low
$1.65

Chart for

About

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications... (more)

Overall

Beta: 1.80
Market Cap(Mil.): $124.20
Shares Outstanding(Mil.): 28.42
Dividend: --
Yield (%): --

Financials

  HTGM.OQ Industry Sector
P/E (TTM): -- 47.86 32.69
EPS (TTM): -0.97 -- --
ROI: -63.13 8.48 12.72
ROE: -130.80 12.20 14.85

BRIEF-HTG Promotes John Lubniewski To President And Chief Operating Officer

* HTG PROMOTES JOHN LUBNIEWSKI TO PRESIDENT AND CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 16 2018

BRIEF-HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work

* HTG MOLECULAR DIAGNOSTICS INC - ON MARCH 30, 2018, CO AND QIAGEN MANCHESTER LIMITED ENTERED SECOND AMENDMENT OF FIRST STATEMENT OF WORK - SEC FILING

Apr 04 2018

BRIEF-Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial

* HTG MOLECULAR DIAGNOSTICS SECURES DEBT FACILITY WITH MIDCAP FINANCIAL

Mar 27 2018

Earnings vs. Estimates